Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
about
Perioperative blood transfusions and recurrence of colorectal cancerNeoadjuvant chemoradiation therapy and pathological complete response in rectal cancerMagnetic resonance imaging in rectal cancer: a surgeon's perspectiveCan the prognosis of colorectal cancer be improved by surgery?What Are the Best Questionnaires To Capture Anorectal Function After Surgery in Rectal Cancer?Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial.Laparoscopy for colon and rectal cancerImproving the outcomes in oncological colorectal surgeryLaparoscopic right hemicolectomy with complete mesocolic excision provides acceptable perioperative outcomes but is lengthy--analysis of learning curves for a novice minimally invasive surgeonPhase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.Resection of rectal cancer: laparoscopy or open surgery?Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades.Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma?Recent advances in the management of carcinoma of the rectumMeta-analysis of defunctioning stoma in low anterior resection with total mesorectal excision for rectal cancer: evidence based on thirteen studies.Oncological superiority of extralevator abdominoperineal resection over conventional abdominoperineal resection: a meta-analysis.Modern management of colorectal cancer--a pathologist's view.Survival of patients with colon and rectal cancer in central and northern Denmark, 1998-2009.Recent randomised trials in colorectal disease.Prognostic implication of metastatic lymph node ratio in node-positive rectal cancer.Comparison of Transanal Endoscopic Microsurgery and Total Mesorectal Excision in the Treatment of T1 Rectal Cancer: A Meta-Analysis.Advances and challenges in treatment of locally advanced rectal cancer.A review of controversies in the management of colorectal cancers.Do all locally advanced rectal cancers require radiation? A review of literature in the modern era.Rectal cancer: the role of radiotherapy.Laparoscopic total mesorectal excision of low rectal cancer with preservation of anal sphincter: a report of 82 cases.Chemoradiotherapy with 5-fluorouracil/leucovorin, surgery and adjuvant chemotherapy for locally advanced rectal cancer.Variation in treatment modalities, costs and outcomes of rectal cancer patients in Poland.Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer.Preoperative bowel preparation: surgical standard or past?Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence.Survival from cancer of the rectum in England and Wales up to 2001.Total mesorectal excision and management of rectal cancer.Defining preoperative treatment strategies in t3 rectal cancer.Neoadjuvant treatment of rectal cancer: where are we now?Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study.Evolving management of colorectal cancer.Lapatinib-capecitabine versus capecitabine alone as radiosensitizers in RAS wild-type resectable rectal cancer, an adaptive randomized phase II trial (LaRRC trial): study protocol for a randomized controlled trialA randomized controlled trial of the conventional technique versus the no-touch isolation technique for primary tumor resection in patients with colorectal cancer: Japan Clinical Oncology Group Study JCOG1006.
P2860
Q24244558-BF5BAA98-8B67-46F6-8FD8-6CF3EE514C66Q26796352-19D77B2A-4852-43FA-8433-A0BC765C62C5Q27027906-B2DD8CEF-BF80-4103-9829-94C6B4D6CACBQ28075949-5D37F7CE-2BC8-42EF-83A5-660C3E84C2D2Q28085690-06EC34AF-0098-48AD-8D27-72859EF67BA5Q33415864-D49F8127-BE57-43DF-BD1E-7144D3C0D6DAQ33772054-DFC58EFF-AD69-4530-89B3-8089C005093BQ34207797-C8147CEA-6A73-4F01-BF7C-FA12D740C6FFQ34282847-535DEBE0-C9FF-4429-8E31-89FFB35BD8C0Q34344547-41103EDE-AD69-4CBA-A689-31BFFB5E0590Q34512088-4B27A544-0BA1-4502-810E-D5C17DE6C904Q34537462-33FA3839-747F-440C-A925-F4AAC4F91EB2Q34719568-B6E819D8-C8C0-41EB-8FD1-A79B690E2490Q35026254-946C381E-4819-4D96-8525-5B62F1FF568FQ35030365-3FBF1AA1-8BDA-4A74-9322-22E731A9EA38Q35079698-2A1E5D7A-A390-4D3F-9EED-6A871DA01D69Q35111158-3F4CBDB8-FA4C-4AD2-97F4-D44622710BF6Q35131245-9A7E24DD-2B05-41D4-A9F5-C5AC7B4E3594Q35157518-512B285E-FA16-4377-8977-76A3D709FA90Q35483162-A5C7A28F-3752-4896-B1F0-4AE273C84CB5Q35822871-D3F1ABD7-356C-4F26-8171-270BCFE97674Q36025983-D857EB15-89F4-445C-A418-C84C728ECC2EQ36095812-97F92FA0-C61E-4979-ABAE-28B8CFA5096EQ36097082-481B25B9-3707-4F76-A5CB-BFED0250E8BFQ36101559-F8DF9250-F1B1-4FDB-B230-B6068DD739DCQ36190645-44498D3C-EFFF-4D77-94CC-25727D35413BQ36216917-49433853-79A9-4690-B9F2-C6B5B34996AFQ36452898-32FF8C53-0180-43BB-A32F-2B064FF71DFAQ36646705-59565AA1-9D97-4A29-BDBE-8A490B56DCDCQ36681867-BD7F4BD7-D7EF-42D5-B38F-F3C261A5375CQ36758901-42AFE2CC-F971-4BC1-9DC9-AEBB828B0C03Q36791079-C724DBF8-FC3B-401E-9B78-8A7AB6C33789Q36917734-61B911D0-4FBE-4802-9704-82BA678BA936Q36974695-B8C12701-FAF2-4891-B90A-46163229C0F1Q37141648-792E4163-1CA1-453D-B46B-A3F545CFEF4AQ37158143-17E360FF-3368-42D2-B017-3D68D30DE3F0Q37172593-63DF8553-3B01-4CE8-A73B-E8D707303432Q37210172-7D8237BD-C3FA-4FF8-BD92-2B1439AEF159Q37272825-9D61075C-4109-4CBA-83C4-EDA937D96214Q37430816-A2BED4D1-7768-45BD-B49D-1E8D4BFBB258
P2860
Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Impact of the introduction and ...... tal cancer in The Netherlands.
@en
Impact of the introduction and ...... tal cancer in The Netherlands.
@nl
type
label
Impact of the introduction and ...... tal cancer in The Netherlands.
@en
Impact of the introduction and ...... tal cancer in The Netherlands.
@nl
prefLabel
Impact of the introduction and ...... tal cancer in The Netherlands.
@en
Impact of the introduction and ...... tal cancer in The Netherlands.
@nl
P2093
P2860
P1476
Impact of the introduction and ...... tal cancer in The Netherlands.
@en
P2093
C J H van de Velde
Cooperative investigators of the Dutch ColoRectal Cancer Group
E Kapiteijn
P2860
P304
P356
10.1046/J.1365-2168.2002.02196.X
P407
P577
2002-09-01T00:00:00Z